Last reviewed · How we verify
NCT04182022
Financially Sustainable Remote Treatment for Alcohol Abuse: Feasibility
NA trial testing Contingency management: Contingent incentives in Alcohol Use Disorder in 92 participants. Completed in 10 July 2019.
10 July 2019
Quick facts
| Lead sponsor | Virginia Polytechnic Institute and State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 92 |
| Start date | 1 December 2016 |
| Primary completion | 10 July 2019 |
| Estimated completion | 10 July 2019 |
Drugs / interventions tested
- Contingency management: Contingent incentives
- Contingency management: Noncontingent incentives
Conditions studied
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
Sponsor
Virginia Polytechnic Institute and State University
Who can join
Adults 18 to 90, any sex, with Alcohol Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this feasibility study is to use a breathalyzer and cost-controlling deposit contracts to facilitate a contingency-management intervention to reduce alcohol use that requires no in-person contact between the participants and the study staff during the intervention phase.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Remotely administered incentive-based treatment for alcohol use disorder with participant-funded incentives is effective but less accessible to low-income participants.
Koffarnus MN, Kablinger AS, Kaplan BA, Crill EM. · · 2021 · cited 16× · PMID 34110885 · DOI 10.1037/pha0000503
Verify or expand the search:
- PubMed search for NCT04182022
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Contingency management: Contingent incentives
Trials testing the same drug.
- NCT03507075 — Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement: Feasibility · Phase 1, PHASE2 · completed
Other recruiting trials for Alcohol Use Disorder
Currently open trials in the same condition.
- NCT06860607 — Environment and Alcohol: A Pilot Study · Phase 1 · recruiting
- NCT07325266 — Human Laboratory Study of Apremilast for Alcohol Use Disorder · Phase 2 · recruiting
- NCT07046819 — Tirzepatide in MetALD · Phase 2 · recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
- NCT07056894 — Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis · NA · recruiting
Other Virginia Polytechnic Institute and State University trials
Trials by the same sponsor.
- NCT07521072 — Testing an Intervention for College Students With Food Insecurity and Binge Eating · EARLY_PHASE1 · not yet recruiting
- NCT07042373 — Effects of Tobacco Abuse Liability-dependent Taxes in the ETM · NA · not yet recruiting
- NCT07158749 — Generalized and Domain-Specific Episodic Thinking for Smoking Cessation · NA · not yet recruiting
- NCT07457710 — Remote Haptic Rehabilitation for Parkinson's Disease · NA · not yet recruiting
- NCT05103514 — The Longitudinal Impact of SES and the CNDS on Recovery From SUD · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04182022 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Virginia Polytechnic Institute and State University
- Last refreshed: 7 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04182022.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing